Vaxcyte, Inc.
PCVX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $388 | $397 | $835 | $69 |
| Short-Term Investments | $1,359 | $683 | $97 | $177 |
| Receivables | $21 | $4 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $20 | $12 | $11 | $10 |
| Total Curr. Assets | $1,788 | $1,096 | $943 | $256 |
| Property Plant & Equip (Net) | $270 | $111 | $32 | $36 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1,388 | $163 | $27 | $27 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $66 | $39 | $5 | $5 |
| Total NC Assets | $1,723 | $312 | $64 | $68 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,511 | $1,408 | $1,006 | $324 |
| Liabilities | – | – | – | – |
| Payables | $48 | $15 | $10 | $7 |
| Short-Term Debt | $6 | $7 | $6 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $86 | $124 | $25 | $17 |
| Total Curr. Liab. | $140 | $145 | $41 | $29 |
| LT Debt | $65 | $22 | $12 | $12 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $65 | $22 | $12 | $12 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $71 | $29 | $18 | $17 |
| Total Liabilities | $205 | $167 | $53 | $40 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,388 | -$924 | -$522 | -$299 |
| AOCI | -$4 | $0 | -$0 | -$0 |
| Other Equity | $4,698 | $2,165 | $1,476 | $583 |
| Total Equity | $3,306 | $1,240 | $954 | $284 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,511 | $1,408 | $1,006 | $324 |
| Net Debt | -$317 | -$368 | -$817 | -$52 |